Latest News

Similarweb (SMWB) has drawn fresh attention after launching AI Studio, an enterprise AI intelligence platform that lets clients query its extensive digital data through conversational research, deep reports, and auto generated dashboards for business decision support. See our latest analysis for Similarweb. The AI Studio launch and Bloomberg Terminal integration arrive during a weak patch for the stock, with Similarweb’s 30 day share price return of 39.16% and year to date share price return...

Matic recently announced a partnership with nCino to embed its home insurance marketplace directly into nCino’s mortgage point of sale platform, allowing borrowers to shop for coverage within the digital loan process. This integration extends nCino’s mortgage workflow into adjacent insurance services, potentially making its platform more valuable to both lenders and borrowers. Next, we’ll examine how embedding Matic’s home insurance marketplace into nCino’s mortgage platform could influence...

Why Gaming and Leisure Properties Is On Investors’ Radar Gaming and Leisure Properties (GLPI) has drawn attention after a recent stretch of steady share performance, with modest gains over the past month and past 3 months prompting a closer look at its fundamentals. See our latest analysis for Gaming and Leisure Properties. At a share price of US$46.20, Gaming and Leisure Properties has seen steady momentum build, with a 30 day share price return of 2.51% and a 5 year total shareholder return...

Why R&S Group Holding’s latest guidance and dividend decision matter R&S Group Holding (SWX:RSGN) has set fresh expectations for FY2025, pairing new earnings guidance for organic net sales growth of 8 to 12% over the cycle with a confirmed proposed dividend of CHF 0.50 per share. For you as an investor, this combination of quantified growth ambitions and a specific cash payout level provides clearer signals on how management is thinking about balancing reinvestment in the business with direct...

Saipem (BIT:SPM) has attracted fresh attention after agreeing to supply an underwater remotely operated vehicle to Italy's ISPRA, linking its subsea engineering expertise directly to oceanographic research and potential long term project visibility. See our latest analysis for Saipem. The ISPRA contract lands at a time when Saipem’s share price has a 30 day return of 21.73% and a 90 day return of 43.87%, with 1 year total shareholder return of 54.62% pointing to strong recent momentum after a...

Applied Optoelectronics (AAOI) has broken ground on a new 210,000 square foot manufacturing facility in Sugar Land, Texas, and has doubled its planned investment in the site to US$300 million to support data center demand. See our latest analysis for Applied Optoelectronics. The new Sugar Land expansion comes after a sharp run in the share price. The 90 day share price return is 104.94% and the 3 year total shareholder return is very large. This suggests momentum has been strong even after a...

If you are trying to figure out whether CAVA Group's share price lines up with its fundamentals, the valuation story is where things start to get interesting. The stock last closed at US$63.61, with a 7 day return of a 1.5% decline, a 30 day return of a 7.2% decline, a year to date return of 5.1% and a 1 year return of a 51.3% decline, which may catch the eye of investors thinking about potential upside or changing risk. Recent coverage around CAVA Group has mainly focused on its position...

MEGMILK SNOW BRAND Co., Ltd. recently held its nine months 2026 earnings call on February 13, 2026, updating investors on the company’s latest financial and operational performance. The call offered fresh detail on how management is executing its current business plan and responding to recent industry conditions, providing investors with new context for assessing the company. We’ll now examine how the earnings call’s updated management commentary may influence MEGMILK SNOW BRAND’s broader...

State Street (NYSE:STT) has launched a new actively managed Prime Money Market ETF, targeting investors who want exchange traded access to cash management. The company has also reached a wealth management technology agreement with Mariner, which will use State Street's Charles River platform. Together, these moves expand State Street's product shelf and deepen its role as a technology partner for financial advisors. For you as an investor, this combination of a new Prime Money Market ETF...

Royal Caribbean Cruises (NYSE:RCL) announced its first stand-alone Royal Beach Club, expanding its leisure offerings beyond ships. The company also reported a higher quarterly dividend, indicating a change in its shareholder payout level. Both updates were recently communicated as part of Royal Caribbean's ongoing product and capital allocation plans. Royal Caribbean operates one of the largest global cruise brands, with revenue tied to ticket sales and onboard spending. The new beach club...

Why Praxis Precision Medicines stock is back on investors’ radar Praxis Precision Medicines (PRAX) has drawn fresh attention after multiple analysts expressed confidence in its lead drug candidates, alongside upcoming NDA submissions for ulixacaltamide and relutrigine, both with Breakthrough Therapy Designation. See our latest analysis for Praxis Precision Medicines. The recent 2.98% 1 day share price return and 18.55% 30 day share price return, on top of a 1 year total shareholder return of...

Bank OZK stock snapshot after recent movement Bank OZK (OZK) shares recently closed at $48.88. The 1 day and 7 day returns are slightly negative, while the stock shows gains over the past month, past 3 months and year to date. See our latest analysis for Bank OZK. The recent 1 day share price return of 0.75% and 7 day share price return of 2.02% follow stronger gains, with a 30 day share price return of 5.10% and a 90 day share price return of 10.84%. However, the 1 year total shareholder...

Bristol-Myers Squibb (NYSE:BMY) reported strong fourth quarter earnings, supported by a growth portfolio that includes several products now generating more than $1b in annual sales. The company highlighted upcoming pivotal pipeline readouts that could influence its future product mix and long term revenue profile. Bristol-Myers Squibb announced recent business moves, including the acquisition of Orbital Therapeutics, a collaboration with BioNTech, and plans for a new research facility. These...

If you are wondering whether Synchrony Financial's current share price reflects its true worth, you are not alone. This article is built to help you size that up. The stock closed at US$71.11, with returns of a 3.9% decline over 7 days, an 8.9% decline over 30 days, a 16.0% decline year to date, but a 13.0% gain over 1 year, 113.4% over 3 years and 117.1% over 5 years. Recent price moves sit against a backdrop of ongoing focus on consumer credit trends, funding costs and card spending...

Bitdeer Technologies Group (NasdaqCM:BTDR) just posted its FY 2025 third quarter numbers with revenue of US$169.7 million, a basic EPS loss of US$1.28 per share and net income loss of US$266.7 million, putting profitability firmly in focus for investors. The company has seen quarterly revenue move from US$70.1 million in Q1 2025 and US$155.6 million in Q2 2025 to US$169.7 million in Q3. Over the same period, EPS moved from a profit of US$2.15 in Q1 to losses of US$0.76 and US$1.28 in Q2 and...

Global Partners LP recently declared a cash distribution of US$0.7600 per unit (US$3.04 on an annualized basis) for the October–December 2025 period, payable on February 13, 2026 to unitholders of record as of February 9, 2026, and scheduled its fourth-quarter and full-year 2025 results release for February 27, 2026. This distribution decision, coming just ahead of the upcoming earnings release, highlights management’s current capital return priorities and income profile for...

Covista, formerly Adtalem Global Education, has announced a corporate rebrand. The company has partnered with Google Cloud to launch AI credential programs for healthcare professionals. The rebrand and partnership highlight a sharpened focus on technology enabled healthcare education. These developments are material for Covista's positioning as a healthcare workforce education provider on the NYSE:ATGE. For you as an investor, the Covista rebrand and its work with Google Cloud point to a...

Vobile Group (SEHK:3738) has drawn fresh attention after announcing a collaboration with Finloop Finance Technology to tokenize offshore real world assets tied to cultural and creative intellectual property, with the aim of building a compliant IP backed digital asset ecosystem. See our latest analysis for Vobile Group. The Finloop agreement lands at a time when momentum in Vobile Group’s shares has been picking up, with a 7 day share price return of 37.09% and a year to date share price...

Tidewater recently issued 2026 revenue guidance of US$1.32 billion to US$1.37 billion, reaffirmed vessel utilization near 76%, and left about US$500 million remaining under its share repurchase authorization, while Sagil Capital fully exited its position in the stock. At the same time, Black Bear Value Fund reiterated Tidewater as a key holding, highlighting the company’s sizeable offshore support vessel fleet, reduced debt, and capital return plans as reasons for its continued interest...

IQVIA Holdings (NYSE:IQV) has entered a collaboration with the Duke Clinical Research Institute to advance clinical research in obesity and cardiometabolic trials. The partnership focuses on complex clinical programs and aims to broaden access to diverse patient groups in areas of rising healthcare focus. For investors watching IQVIA Holdings at a share price of $168.85, this new collaboration sits against a backdrop of weak recent returns. The stock has declined 6.7% over the past week,...

MoonStone Phase 2 data and why it matters for Zenas BioPharma (ZBIO) Zenas BioPharma (ZBIO) is in the spotlight after presenting Phase 2 MoonStone trial results for obexelimab in relapsing multiple sclerosis. The drug met its primary endpoint with a highly statistically significant reduction in new active brain lesions. For investors watching ZBIO, the detailed 24 week dataset, together with the late breaking presentation at the ACTRIMS Forum 2026, raises fresh questions about how this...

Safehold (NYSE:SAFE) received an S&P credit rating upgrade to A- with a stable outlook. The company announced a share buyback program alongside plans to monetize more of its unrealized capital appreciation, known as "Carats." Management outlined an expansion of ground lease originations, including a focus on affordable housing and broader geographic reach. Safehold, trading at $14.84, is working to reposition itself in the eyes of both credit markets and equity investors. The stock is up...

What the Hiab partnership could mean for Custom Truck One Source The new dealer agreement between Hiab and Custom Truck One Source (CTOS) expands sales and service coverage for HIAB cranes and MOFFETT forklifts across Western and Northeastern states, providing investors with an additional data point on the company’s growth ambitions. See our latest analysis for Custom Truck One Source. Recent news around the Hiab agreement sits alongside strong share price momentum, with a 22.3% 90 day share...

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...